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Background A cardiac calcified amorphous tumour (CAT) is a non-neoplastic intracavitary cardiac mass. The most serious com-
plication is systemic embolism. Cardiac CATs tend to be surgically resected immediately after detection; therefore,
its progress of growth is rarely reported.
...................................................................................................................................................................................................
Case summary An 83-year-old Japanese woman received on-pump beating coronary artery bypass graft surgery (CABG) for angina
pectoris. Transthoracic echocardiography (TTE) performed preoperatively and 1 month postoperatively revealed
the presence of mitral annular calcification, with no other abnormal findings. However, follow-up TTE performed
5 months after CABG revealed a mobile nodular mass (5.0 8.2 mm) in the left ventricular outflow tract. At
1 month after detection, the mass had enlarged to 5.0 13.0 mm. Transoesophageal echocardiography revealed
that the pedunculated high-echoic mass was adhered to the posterior commissure of the mitral valve and was dy-
namically swinging towards the non-coronary cusp in the systolic phase. As the mass had grown rapidly in less than
6 months, it was surgically resected to prevent systemic embolism. The histological specimen consisted mainly of fi-
brin, including calcification and hemosiderin deposition, which lead to a diagnosis of cardiac CAT. The patient had
an uneventful postoperative course during her hospital stay and had no evidence of recurrence for 1 year after
discharge.
...................................................................................................................................................................................................
Discussion This was a rare case in which a rapidly growing cardiac CAT was detected following on-pump CABG. Cardiac
CATs may grow very rapidly and therefore early surgery should be considered after initial diagnosis.
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Learning points
• A cardiac calcified amorphous tumour (CAT) may grow rapidly in less than 6 months.
• Echocardiography is the most preferable imaging modality for identifying the progression of a cardiac CAT.
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A cardiac calcified amorphous tumour (CAT) is a non-neoplastic
intracavitary cardiac mass composed of nodular calcium deposits
within degenerating blood elements and fibrinous material.1 The con-
ditions most frequently associated with a CAT are valvular disease,
mitral annular calcification (MAC), end-stage renal disease, diabetes,
and coronary disease.2 The mean age at presentation was 54 years,
with a female predominance.2 The most frequent presenting symp-
tom was dyspnoea followed by syncope, leading to detection of pul-
monary and systemic embolization in 31% of the cases.2 A cardiac
CAT is generally surgically removed immediately after its detection;
therefore, little has been reported about the progress of this tumour.
Herein, we report a case of a cardiac CAT that showed rapid growth
on serial echocardiographic imaging following on-pump coronary ar-
tery graft surgery (CABG).
Timeline
Case presentation
An 83-year-old Japanese woman with a history of hypertension and
dyslipidaemia underwent on-pump CABG for angina pectoris with
multi-vessel coronary artery disease. Transthoracic echocardiog-
raphy (TTE) performed preoperatively and 1 month postoperatively
revealed normal wall motion of the left ventricle and the presence of
MAC, with no other abnormal findings (Figure 1A). However, follow-
up TTE performed 5 months after CABG revealed a mobile nodular
mass (5.0 8.2 mm) in the left ventricular outflow tract (LVOT)
(Figure 1B). Considering the risks of non-bacterial thrombotic endo-
carditis or thrombus, the patient was prescribed apixaban 5 mg/day
in addition to the aspirin 100 mg/day that she was taking for known is-
chaemic heart disease. A further 1 month later, the mass had enlarged
to 5.0 13.0 mm (Figure 1C), and the patient was referred to our hos-
pital for further investigation.
Physical examination on admission showed a Levine 2/6 systolic
murmur at the left sternal border, a regular heart rhythm of 61
b.p.m., and blood pressure of 117/71 mmHg. No remarkable symp-
toms were observed. The results of the laboratory study were as fol-
lows: white blood cell count 4200/lL, C-reactive protein 0.04 mg/dL,
serum creatinine 0.63 mg/dL, haemoglobin A1c 6.0% (42 mmol/mol),
and brain natriuretic peptide 317 pg/mL. Blood tests including throm-
botic and autoimmunological parameters were unremarkable, and
blood cultures were negative. Electrocardiography and chest radiog-
raphy revealed no abnormalities. TTE showed no significant valvular
dysfunction or wall-motion asynergy in the left ventricle, though a
mobile cardiac mass was observed in the LVOT. Transoesophageal
echocardiography revealed a pedunculated high-echoic mass that
was adhered to the posterior commissure of the mitral valve and was
dynamically swinging towards the non-coronary cusp of the aortic
valve in the systolic phase (Video 1).
Contrast computed tomography (CT) revealed MAC along almost
the entire posterior leaflet of the mitral valve and a low-density
string-shaped structure at the same site as the mass shown on TTE
(Figure 2A and B). There were no space-occupying lesions suggestive
of metastatic cardiac tumours in the thoracoabdominal CT. Cardiac
cine magnetic resonance imaging (MRI) showed a low-signal intensity
structure between the non-coronary cusp of the aortic valve and the
posterior commissure of the mitral valve (Figure 2C and D).
As the mass had grown rapidly in less than 6 months, surgical re-
section was performed to prevent systemic embolism. The peduncu-
lated mass was vulnerable and was resected successfully (Figure 3).
On gross examination of the resected mass before formalin fixation,
it was yellowish in colour and measured 13.0 5.0 mm (Figure 4A).
The histological specimen which was stained with haematoxylin and
eosin consisted mainly of fibrin, including calcification and hemosi-
derin deposition (Figure 4B). There were no malignant findings and no
bacterial mass detected. Characteristic histologic findings lead to a
diagnosis of cardiac CAT. The patient had an uneventful postopera-
tive course during her hospital stay and had no evidence of recur-
rence for 1 year after discharge.
Discussion
This was a rare case in which a cardiac CAT grew rapidly in less
than 6 months. Cardiac CAT was first reported as a non-neoplastic
cardiac mass in 1997.1 Histologically, a cardiac CAT is composed of
nodular deposits of calcium in a background of amorphous degen-
erated fibrin and focal inflammation.1 In a review of 42 patients with
cardiac CAT, the most frequently associated conditions were valvu-
lar disease (31%), MAC (14%), end-stage renal disease (21%), dia-
betes (14%), and coronary artery disease (12%).2 Cardiac CAT
occasionally leads to systemic embolisms of varying sizes, potentially
causing visual loss due to retinal arterial occlusion, acute cerebral
infarction, iliac artery occlusion, and pulmonary embolism.3–6 A vast
majority of patients underwent surgery had favourable outcomes,
with 5% of postoperative mortality and 2% of recurrence of CAT.2
There are several differential diagnoses including thrombus, infective
endocarditis, non-bacterial thrombotic endocarditis, papillary fibroe-
lastoma, or cardiac tumour such as myxoma.7–11
The present patient underwent on-pump beating CABG without any
intracardiac invasion. There were no remarkable findings on TTE per-
formed 1 month after surgery; therefore, the relationship between the
October 2019 On-pump coronary artery bypass graft surgery
was performed.
November 2019 There were no remarkable findings on follow-up
transthoracic echocardiography (TTE).
March 2020 A mobile cardiac mass (5.0 8.2 mm) was
detected incidentally on follow-up TTE.
April 2020 The mass was 5.0 13.0 mm and its mobility had
increased. Therefore, it was surgically resected.
The mass was diagnosed as a cardiac calcified
amorphous tumour based on pathological
findings.
April 2021 The patient is clinically well without evidence of
recurrence.


















occurrence of the cardiac CAT and the surgery itself remains unclear.
Little is known about the growth rate of cardiac CAT, as the mass in
most reported cases is surgically resected immediately after detection.
In previous reports, patients accompanied with MAC experienced the
rapid development of the cardiac CATs in 6 weeks to 1 year.12,13
Hence, the growth rate of MAC-related cardiac CAT may be relatively
faster than that of CAT in patients without MAC.
The lesions of cardiac CAT were mostly seen as partially calcified
hypodense masses on CT findings.14 In the present case, low-density
mass was observed on contrast CT, which was less clear than that
seen by echocardiography. In the MRI examination, the mass could
be confirmed only by cardiac cine MRI. Given these findings, cardiac
CAT with high mobility might not be reliably assessed by CT or MRI.
In the present case, the cardiac CAT grew rapidly in the last
1 month before resection. Although the best treatment strategy for a
cardiac CAT remains unclarified, we propose the early-stage surgery
after initial diagnosis considering the potential for rapid tumour
growth.
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Figure 1 Postoperative transthoracic echocardiography studies. Transthoracic echocardiography findings at the following three points in time. (A)
Normal wall motion of the left ventricle and the presence of mitral annular calcification, with no other remarkable findings at 1 month after surgery.
(B) The 5.0  8.2-mm mass (white arrow) newly detected 5 months after surgery, which was formed in the left ventricular outflow tract and was
swinging towards the aortic valve in the systolic phase. (C) One month later, the mass had enlarged to 5.0 13.0 mm (yellow arrow). Ao, ascending
aorta; LA, left atrium; LV, left ventricular.
Video 1 Transoesophageal echocardiography showing a nodular
























































.. Slide sets: A fully edited slide set detailing this case and suitable for
local presentation is available online as Supplementary data.
Consent: The authors confirm that written consent for submission
and publication of this case report including images and associated
text has been obtained from the patient in line with COPE guidance.
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